Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
GeneQuantum Healthcare (Suzhou) Co., Ltd.
Scientific Title
A Phase 1, First-In-Human, Multicenter, Open-Label, Study of GQ1001, a HER2 Targeted Antibody-Drug Conjugate, Administered Intravenously, in Adult Patients With HER2-Positive Advanced Solid Tumors